Exagen Inc. (XGN)

USD 4.6

(7.98%)

Total Assets Summary of Exagen Inc.

  • Exagen Inc.'s latest annual total assets in 2023 was 56.94 Million USD , down -33.96% from previous year.
  • Exagen Inc.'s latest quarterly total assets in 2024 Q2 was 49.3 Million USD , down -2.95% from previous quarter.
  • Exagen Inc. reported annual total assets of 86.22 Million USD in 2022, down -30.15% from previous year.
  • Exagen Inc. reported annual total assets of 123.44 Million USD in 2021, up 57.51% from previous year.
  • Exagen Inc. reported quarterly total assets of 49.3 Million USD for 2024 Q2, down -2.95% from previous quarter.
  • Exagen Inc. reported quarterly total assets of 56.94 Million USD for 2023 Q4, down -6.54% from previous quarter.

Annual Total Assets Chart of Exagen Inc. (2023 - 2012)

Historical Annual Total Assets of Exagen Inc. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 56.94 Million USD -33.96%
2022 86.22 Million USD -30.15%
2021 123.44 Million USD 57.51%
2020 78.37 Million USD -11.25%
2019 88.31 Million USD 205.71%
2018 28.88 Million USD 41.67%
2017 20.39 Million USD 0.0%
2015 14.62 Million USD -14.71%
2014 17.14 Million USD 4.24%
2013 16.45 Million USD 46.02%
2012 11.26 Million USD 0.0%

Peer Total Assets Comparison of Exagen Inc.

Name Total Assets Total Assets Difference
Aspira Women's Health Inc. 6.26 Million USD -809.358%
bioAffinity Technologies, Inc. 8.22 Million USD -592.619%
Intelligent Bio Solutions Inc. 13.77 Million USD -313.271%
Standard BioTools Inc. 323.06 Million USD 82.374%
Inotiv, Inc. 856.53 Million USD 93.352%
Prenetics Global Limited 254.17 Million USD 77.596%
Neuronetics, Inc. 115.83 Million USD 50.839%
Star Equity Holdings, Inc. 86.97 Million USD 34.528%
Castle Biosciences, Inc. 477.81 Million USD 88.082%
Psychemedics Corporation 13.27 Million USD -329.118%
RadNet, Inc. 2.88 Billion USD 98.027%
Exact Sciences Corporation 6.47 Billion USD 99.12%
IDEXX Laboratories, Inc. 3.25 Billion USD 98.253%
iSpecimen Inc. 15.81 Million USD -259.969%
OpGen, Inc. 1.88 Million USD -2925.277%
Bionano Genomics, Inc. 214.4 Million USD 73.441%
CareDx, Inc 484.61 Million USD 88.25%
Check-Cap Ltd. 25.01 Million USD -127.621%
Twist Bioscience Corporation 776.4 Million USD 92.666%
Guardant Health, Inc. 1.78 Billion USD 96.812%
Biodesix, Inc. 99.09 Million USD 42.537%
BioNexus Gene Lab Corp. 11.39 Million USD -399.518%
Precipio, Inc. 18.1 Million USD -214.59%
Natera, Inc. 1.45 Billion USD 96.092%
Fulgent Genetics, Inc. 1.27 Billion USD 95.527%
Sera Prognostics, Inc. 95.44 Million USD 40.336%
23andMe Holding Co. 395.16 Million USD 85.59%
OPKO Health, Inc. 2.01 Billion USD 97.169%
Personalis, Inc. 225.09 Million USD 74.703%
Aclaris Therapeutics, Inc. 197.4 Million USD 71.154%
Applied DNA Sciences, Inc. 13.65 Million USD -317.124%
T2 Biosystems, Inc. 34.79 Million USD -63.646%
Neogen Corporation 4.58 Billion USD 98.758%
Myriad Genetics, Inc. 1.19 Billion USD 95.25%
ICON Public Limited Company 16.98 Billion USD 99.665%
NeoGenomics, Inc. 1.68 Billion USD 96.613%
Star Equity Holdings, Inc. 86.97 Million USD 34.528%
MDxHealth SA 129.13 Million USD 55.902%
Prenetics Global Limited 254.17 Million USD 77.596%
Illumina, Inc. 10.11 Billion USD 99.437%
DarioHealth Corp. 96.38 Million USD 40.923%
ENDRA Life Sciences Inc. 6.75 Million USD -743.097%
Medpace Holdings, Inc. 1.65 Billion USD 96.563%
Mainz Biomed B.V. 15.4 Million USD -269.55%
Trinity Biotech plc 59.43 Million USD 4.191%
Sotera Health Company 3.13 Billion USD 98.181%
bioAffinity Technologies, Inc. 8.22 Million USD -592.619%